Become A Featured Company

Invictus MD’s AB Laboratories Rapidly Moves to Market

Ryan Allway

March 27th, 2017

News, Top News

The Canadian cannabis industry could reach $22.6 billion in size, according to Deloitte, driven by nationwide recreational legalization. The retail base market alone is estimated to be worth between $4.9 billion and $8.7 billion per year, which is a significant number given that there are only 40 licensed producers approved by Health Canada. Investors interested in the space may want to take a look at these well-positioned licensed producers.

In this article, we will take a look at Invictus MD Strategies Corp.’s (CSE: IMH) (OTCQB: IVITF) investment in a Canadian licensed producer along with its status in ramping up operations.

Licensed Producer Acquisition

Invictus MD Strategies completed its final commitment with a cash transaction of C$2 million for its 33.33% stake in AB Laboratories Inc. (“AB Labs”) on March 14, which provides valuable access to Canada’s burgeoning cannabis industry. Under the terms of the deal, the company has the first right of refusal to arrange any initial public offering, reverse take-over, or other going-public transaction, while agreeing to commit an additional C$5.5 million to fund the cost of construction and licensing of future capacity.

AB Labs one of about 40 licensed producers under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) with a 16,000 square foot cultivation facility located in Hamilton, Ontario. Recently, the LP plans to close on 100 acres of land in Ontario on May 1, 2017 where it plans to construct five production facilities totaling 100,000 square feet of capacity by 2019 – a move that could help it become a leader in the space.

On March 23, the company announced that AB Labs has completed several test crops in its licensed production facility. While the facility is only operating at half capacity, the company plans to ramp up to full capacity by the end of May 2017. The LP also disclosed that it has already received several direct inquiries from medical marijuana patients, which underscores the continuous growth in demand even before recreational legalization takes effect.

Well-Positioned to Execute

Invictus MD Strategies is well-positioned to execute on its goal of building a portfolio of licensed producers to capitalize on Canada’s burgeoning cannabis industry. With $15.5 million in cash on its balance sheet, the company has ample resources to execute the initial expansion of AB Labs business with construction plans already underway and expected to be submitted to Health Canada by May 1, 2017.

The company’s management team has established a strong track record building value in companies that it has acquired. For example, the team acquired an 82.5% stake in Future Harvest – a 20 year old hydroponics and indoor growing firm – and sold its lighting division for 350% return on investment. It used the $4.8 million in cash to reinvest in its nutrients business and increased 2016 revenue by 50% year-over-year.

On March 24, the company announced the appointment of Mr. George E. Kveton to its Board of Directors. Mr. Kveton is a founding partner of LOGSCALE Venture Partners and a highly effective, strategic, and pragmatic international executive and investment professional with broad experience operating in both Fortune 500 and startup environments. In particular, his strengths lie in executing cross-border M&A deals and executing deals in regulated markets.

Looking Ahead

Invictus MD Strategies Inc. (CSE: IMH) (OTCQB: IVITF) represents a compelling investment opportunity in the cannabis sector. With a highly capable management team at the helm, the company is well-positioned to capitalize on its 33.33% acquisition of a licensed producer in Canada as well as its other acquisitions target the lucrative industry. Investors may want to take a closer look given the stock’s modest market capitalization.

For more information, visit the company’s website or CannabisFN’s company profile.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading